A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei. Vaccine, 36(32 Pt B), 4880-4889. presented at the 2018 08 06. doi:10.1016/j.vaccine.2018.06.063. (2018).
Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Clin Vaccine Immunol, 23(12), 918-925. presented at the 2016 Dec. doi:10.1128/CVI.00399-16. (2016).